Spirulina and Mitochondrial Biogenesis.

PGC-1α as Master Biogenesis Co-activator

PGC-1α (PPARGC1A; 798 aa) is the master transcriptional co-activator of mitochondrial biogenesis. It contains three LXXLL co-activator motifs and a C-terminal arginine/serine (RS) and RNA recognition motif (RRM). PGC-1α co-activates: NRF1 and NRF2/GABPA (nuclear respiratory factors; NRF1 binds NRF1-RE 5′-GCGCATGCGC-3′; drives OXPHOS subunit genes NDUFA9, SDHA, UQCRB, COX5B, ATP5A1, CYC1, and TFAM); ERRα/γ (oestrogen-related receptors; drive MCAD, CPT1A, PDHA1, and mtDNA biogenesis); PPAR-α (FAO, ketogenesis); HNF4α (liver gluconeogenesis in fasting); FOXO3a (antioxidant programme: SOD2, CAT, GPx1). PGC-1α transcription is driven by CREB Ser133 (cAMP/PKA; exercise; fasting); AMPK (direct phosphorylation Thr177/Ser538 activates pre-existing PGC-1α protein; AMPK also activates PPARGC1A transcription via CREB); MEF2 (muscle); and by SIRT1→p65 Lys310 deacetylation (relieving NF-κB repression of PPARGC1A promoter κB site at −500 bp).

TFAM: mtDNA Packaging and Replication

Mitochondrial transcription factor A (TFAM; 246 aa; two HMG-box domains; mitochondrial targeting sequence Ala1–Ala42) is the primary mtDNA-packaging protein (one TFAM per ~16 bp; ~1,500 TFAM molecules per mitochondrion) and transcription activator at LSP (light strand promoter) and HSP1/2 (heavy strand promoters) of the D-loop. TFAM bends mtDNA ~180° by intercalating Leu182 and Ile80 into the minor groove. TFAM drives: mtDNA copy number (stoichiometric; TFAM protein ↓ 50% → mtDNA copy number ↓ 50%); mtRNA synthesis (12S rRNA, 16S rRNA, and 13 polypeptides of OXPHOS: ND1-6, ND4L, COX1-3, ATP6/8, Cytb); and mtDNA repair (TFAM compaction protects against 8-OHdG generation). TFAM mRNA has a TFBS for NRF1 in its promoter (NRF1→TFAM; PGC-1α→NRF1→TFAM cascade). TFAM protein is degraded by LonP1 (mitochondrial quality control protease) when mtDNA is damaged beyond repair.

PINK1/Parkin Mitophagy: Quality Control

Mitophagy removes dysfunctional mitochondria (low Δψm) to prevent ROS amplification. PINK1 (PTEN-induced kinase 1; Ser/Thr kinase; MTS aa 1–155) is constitutively imported into healthy mitochondria (high Δψm) → PARL protease cleavage→IAP-mediated degradation → PINK1 <1 min half-life. When Δψm ↓ (damaged mitochondrion) → PINK1 import stops → PINK1 accumulates on OMM (outer mitochondrial membrane) → PINK1 autophosphorylation Ser228/Thr257 → PINK1 phosphorylates ubiquitin Ser65 and Parkin UBL domain Ser65 → Parkin E3 ligase activity maximally activated (>1,000-fold) → Parkin K63-Ub tags: MFN1/2 Lys867/882 (→ K48 by MARCHF5), VDAC1, Miro1/2, TOMM20 → p62/SQSTM1 + NDP52 + OPTN autophagy receptors bind K63/K48-Ub chains → LC3-II phagophore docking → selective mitophagy. PINK1 also phosphorylates MFN2 Thr111/Ser378 → Parkin-MFN2 interaction → fission-mitophagy coupling.

Spirulina’s Mechanistic Actions

• AMPK → PGC-1α ↑: AMPK Thr172 ↑ → PGC-1α Thr177/Ser538 phosphorylation (acute activation of pre-existing protein) + PPARGC1A promoter induction via CREB Ser133 → PGC-1α mRNA ↑ 20–35%; PGC-1α protein ↑ 15–30%.
• NAD&sup+; ↑ → SIRT1 → PGC-1α Lys13/14 deacetylation ↑: Spirulina NAD&sup+; ↑ 20–35%→SIRT1 ↑→PGC-1α Lys13/14 deacetylation → PGC-1α transcriptional co-activator activity ↑→NRF1→TFAM ↑ 15–25%→mtDNA copy number ↑ 15–25%.
• NRF1→OXPHOS subunits ↑: NDUFA9 (complex I) ↑ 15–25%; SDHA (complex II/SIRT3) ↑ 10–20%; UQCRB (complex III) ↑ 10–20%; ATP5A1 (complex V) ↑ 10–20%; citrate synthase activity ↑ 15–30% (biomarker of mitochondrial mass); O&sub2; consumption rate (OCR) ↑ 15–25% in spirulina-treated myotubes/hepatocytes.
• SIRT3 → OXPHOS deacetylation ↑: SIRT3 NAD&sup+;-dependent activation (SIRT3→NDUFA9 Lys; SIRT3→SDHA Lys335; SIRT3→ATP5A1 Lys) → complex I/II/V activity ↑ 20–35%; ATP synthesis efficiency ↑; mitochondrial membrane potential Δψm ↑ 20–30%.
• PINK1/Parkin mitophagy quality control: AMPK→ULK1 Ser555→PINK1-Parkin pathway amplification (ULK1 phosphorylates FUNDC1 and Beclin-1 for mitophagy initiation); Δψm maintained (SIRT3→SOD2/complex I) reduces PINK1 stabilisation on healthy mitochondria; net: defective mitochondria selectively eliminated (mitophagy ↑ 10–20%), healthy mitochondria biogenesis ↑ → net functional mitochondrial content ↑ 15–30%.

Clinical Correlates and Dosing

Animal models: spirulina (50–200 mg/kg) increases citrate synthase activity 15–30% in liver, muscle, and heart; mtDNA copy number ↑ 15–25%; TFAM ↑ 15–20%; OCR ↑ 15–25%. In ageing rodents, PGC-1α→SIRT3 cascade restored to young-animal levels with 8 weeks supplementation. Human: VO&sub2;max ↑ 2–5% in athletes (2 RCTs; 4 g/day, 8 weeks) and 3–6% in sedentary individuals, consistent with mitochondrial biogenesis. Exercise + spirulina: additive mitochondrial biogenesis via independent AMPK/PGC-1α activation routes. Interactions: mitochondria-targeted antioxidants (MitoQ, SS-31) + spirulina — potentially additive; no adverse interactions reported.